Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 05 04:00PM ET
1.89
Dollar change
-0.06
Percentage change
-3.08
%
Index- P/E- EPS (ttm)-1.83 Insider Own20.15% Shs Outstand2.25M Perf Week-9.13%
Market Cap4.25M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.80M Perf Month3.85%
Income-4.03M PEG- EPS next Q- Inst Own8.88% Short Float1.02% Perf Quarter-13.70%
Sales0.00M P/S- EPS this Y- Inst Trans121.47% Short Ratio0.03 Perf Half Y-36.15%
Book/sh-0.56 P/B- EPS next Y- ROA-139.98% Short Interest0.02M Perf Year-31.77%
Cash/sh1.16 P/C1.63 EPS next 5Y- ROE-163.33% 52W Range1.31 - 4.42 Perf YTD-19.57%
Dividend Est.- P/FCF- EPS past 5Y-4.05% ROI-179.56% 52W High-57.24% Beta-0.14
Dividend TTM- Quick Ratio6.33 Sales past 5Y0.00% Gross Margin- 52W Low44.27% ATR (14)0.24
Dividend Ex-Date- Current Ratio6.33 EPS Y/Y TTM50.38% Oper. Margin0.00% RSI (14)50.25 Volatility14.98% 10.82%
Employees4 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q55.12% Payout- Rel Volume0.09 Prev Close1.95
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume603.56K Price1.89
SMA201.86% SMA500.77% SMA200-19.59% Trades Volume51,789 Change-3.08%
Sep-11-24 01:00PM
Sep-04-24 08:30AM
Aug-26-24 08:30AM
Aug-19-24 08:30AM
Aug-16-24 08:53PM
08:30AM Loading…
Aug-15-24 08:30AM
Aug-14-24 10:50PM
Jun-14-24 11:00AM
09:30AM
Jun-06-24 08:30AM
Jun-03-24 08:30AM
May-20-24 08:30AM
May-09-24 01:53PM
May-08-24 09:25AM
Mar-27-24 08:30AM
08:30AM Loading…
Mar-21-24 08:30AM
Feb-27-24 08:30AM
Feb-26-24 08:30AM
Jan-29-24 08:30AM
Nov-13-23 08:30AM
Oct-16-23 08:30AM
Oct-09-23 08:30AM
Sep-26-23 08:30AM
Sep-20-23 08:30AM
Jul-20-23 04:05PM
Jul-18-23 08:00AM
Jul-17-23 08:30AM
Jun-23-23 08:30AM
Jun-07-23 08:30AM
Jun-05-23 09:41AM
12:30PM Loading…
Jun-02-23 12:30PM
May-30-23 08:30AM
Apr-24-23 08:30AM
Apr-04-23 08:30AM
Feb-14-23 01:50PM
Feb-08-23 05:26AM
Feb-07-23 12:58PM
12:16PM
Dec-05-22 08:30AM
Nov-30-22 08:05AM
Oct-13-22 08:30AM
Jun-21-22 08:30AM
Jun-15-22 08:30AM
Apr-14-22 06:45PM
02:54PM
Apr-13-22 10:54AM
10:00AM
09:00AM
08:30AM
Apr-12-22 03:20PM
01:53PM
09:27AM
08:30AM
Mar-22-22 08:30AM
Mar-16-22 08:30AM
Jan-12-22 08:30AM
Jan-05-22 09:18AM
08:30AM
Nov-22-21 09:25AM
Oct-20-21 09:25AM
Oct-13-21 09:25AM
Sep-24-21 09:31AM
Aug-17-21 11:02AM
09:25AM
Aug-03-21 09:25AM
Jul-22-21 09:25AM
Jul-13-21 09:25AM
Jul-07-21 09:35AM
Jun-26-21 05:45AM
Jun-03-21 08:22AM
Jun-02-21 09:35AM
May-18-21 05:30PM
May-12-21 09:35AM
May-04-21 04:30PM
Apr-28-21 09:35AM
Apr-13-21 09:35AM
Mar-17-21 09:35AM
Mar-03-21 09:35AM
Mar-02-21 06:38PM
03:40PM
10:30AM
Mar-01-21 08:45AM
Feb-26-21 11:58AM
Feb-25-21 02:37AM
Jan-19-21 09:35AM
Dec-01-20 03:28PM
12:30PM
Nov-30-20 03:52PM
Nov-25-20 08:30AM
Aug-18-20 09:35AM
Jul-21-20 09:35AM
Apr-30-20 10:30AM
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Pasadena, CA.